Search
Search Results
-
-
SIRT1-Mediated HMGB1 Deacetylation Suppresses Neutrophil Extracellular Traps Related to Blood–Brain Barrier Impairment After Cerebral Venous Thrombosis
Cerebral venous thrombosis (CVT) is a neurovascular disease with recently increasing incidence. Aseptic inflammatory responses play an important role...
-
Efficacy and safety of direct oral anticoagulants versus warfarin in the treatment of cerebral venous sinus thrombosis
BackgroundGiven the evolving application and promising outcomes of direct oral anticoagulants (DOACs) in various thromboembolic conditions, we aimed...
-
Extracellular Vesicle Biomarkers for Thrombosis
Extracellular vesicles (EVs) participate in thrombosis via the functions of molecule expression on their surfaces, including tissue factor (TF) and...
-
Develo** a risk assessment tool for cancer-related venous thrombosis in China: a modified Delphi-analytic hierarchy process study
ObjectiveTo develop a Risk Assessment Tool for Cancer-related Venous Thrombosis in China.
MethodsA modified two-round Delphi method was employed to...
-
Assessment of fibrinogen albumin ratio in patients with pregnancy-related cerebral venous thrombosis
Introduction and objectiveCerebral venous thrombosis (CVT) is a cerebrovascular disease observed more commonly in women of childbearing age. There is...
-
Phloretin targets SIRT1 to alleviate oxidative stress, apoptosis, and inflammation in deep venous thrombosis
Deep vein thrombosis (DVT) is a type of venous thromboembolism posing a serious threat to health on a global scale. Phloretin is a potential natural...
-
Neutrophil-to-lymphocyte ratio is a novel predictor of venous thrombosis in polycythemia vera
We investigated the neutrophil-to-lymphocyte ratio (NLR) as a predictor of thrombosis in polycythemia vera (PV). After a median follow-up of 2.51...
-
Cerebral venous sinus thrombosis presenting with subarachnoid hemorrhage: a series of 11 cases
Background and purposeCerebral venous sinus thrombosis (CVST) is a rare cerebrovascular disease with a wide spectrum of clinical manifestations. The...
-
Characteristics of patients with cerebral sinus venous thrombosis and JAK2 V617F mutation
ObjectivesJanus kinase 2 (JAK2–V617F) mutations can cause thrombocytosis, polycythemia and hyper viscosity leading to cerebral sinus venous...
-
-
Cerebral Venous Thrombosis
Cerebral venous thrombosis (CVT) is a relatively uncommon but serious neurologic disorder that is potentially reversible with prompt diagnosis and...
-
Long-term outcome of patients with vaccine-induced immune thrombotic thrombocytopenia and cerebral venous sinus thrombosis
We present the long-term outcomes of 44 patients who developed cerebral venous sinus thrombosis after vaccination with the adenoviral vector ChAdOx1...
-
D-dimer/fibrinogen ratio for the prediction of deep venous thrombosis after traumatic spinal cord injury
Study designRetrospective cohort study.
ObjectivesTo evaluate the predictive value of D-dimer/fibrinogen (D/F) ratio for deep vein thrombosis (DVT)...
-
Effect of Oligochitosan on Experimental Venous Thrombosis in Guinea Pigs
Oligochitosan Сh10/85 with a molecular weight of 10 kDa and a deacetylation degree of 85% prevented the development of experimental venous thrombosis...
-
-
The impact of thrombosis on probabilities of death and disease progression in polycythemia vera: a multistate transition analysis of 1,545 patients
We applied a parametric Markov five-state model, on a well-characterized international cohort of 1,545 patients with polycythemia vera (PV; median...
-
Venous Thromboembolism: Review of Clinical Challenges, Biology, Assessment, Treatment, and Modeling
Venous thromboembolism (VTE) is a massive clinical challenge, annually affecting millions of patients globally. VTE is a particularly consequential...
-
Pediatric cerebral sinus venous thrombosis: clinical characterization of a Portuguese cohort
IntroductionPediatric cerebral sinus venous thrombosis (CSVT) is a rare entity. Risk factors differ from the adults, and treatment is not consensual....
